Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 6/20 | 0.54 |
| ▸ | KDM5A | P29375 | 4/20 | 0.54 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.54 |
| ▸ | KDM5C | P41229 | 1/20 | 0.51 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.51 |
| ▸ | KDM4A | O75164 | 2/20 | 0.50 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.50 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.50 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.50 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | PPARG | P37231 | 7/20 | 0.48 |
| ▸ | PPARD | Q03181 | 7/20 | 0.48 |
| ▸ | PPARA | Q07869 | 7/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8093289 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL5984529 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL28942179 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL16895244 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL41611 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL5984033 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL73050 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL10610457 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL1272817 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL27082196 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4021643-B1 | A COLLECTOR COMPOSITION FOR THE LITHIUM ORE OR MAGNESIUM ORE FLOTATION | BASF SE (DE) | 2025-12-03 | — | — | EP | claimed |
| US-12478982-B2 | Collector composition | BASF SE (DE) | 2025-11-25 | — | — | US | claimed |
| US-20220266262-A1 | A COLLECTOR COMPOSITION | BASF SE (DE) | 2022-08-25 | — | — | US | claimed |
| EP-4021643-A1 | A COLLECTOR COMPOSITION FOR THE LITHIUM ORE OR MAGNESIUM ORE FLOTATION | BASF SE (DE) | 2022-07-06 | — | — | EP | claimed |
| EP-1582196-B1 | Translucent nanoemulsion, production method, and uses thereof in the cosmetic, dermatological and/or ophthalmological fields. | OREAL (FR) | 2011-08-24 | — | — | EP | claimed |
| US-20070134167-A2 | Stable foam cream | NEUBOURG SKIN CARE GMBH & CO. KG (DE) | 2007-06-14 | — | — | US | claimed |
| US-20060239937-A2 | STABLE FOAM CREAM | NEUBOURG SKIN CARE GMBH AND CO KG (DE) | 2006-10-26 | — | — | US | claimed |
| US-20060099151-A1 | Stable foam cream | NEUBOURG FRITZ | 2006-05-11 | — | — | US | claimed |
| EP-4715960-A1 | METHOD FOR OPERATING A THERMAL MANAGEMENT ARRANGEMENT | Dr. Ing. h.c. F. Porsche Aktiengesellschaft (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-4715023-A1 | HEAT TRANSFER FLUID | ExxonMobil Technology and Engineering Company (US) | 2026-03-25 | — | — | EP | disclosed |
| US-20260081259-A1 | METHOD FOR OPERATING A THERMAL MANAGEMENT ARRANGEMENT | ExxonMobil Technology and Engineering Company (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4021643-B1 | A COLLECTOR COMPOSITION FOR THE LITHIUM ORE OR MAGNESIUM ORE FLOTATION | BASF SE (DE) | 2025-12-03 | — | — | EP | disclosed |
| US-12478982-B2 | Collector composition | BASF SE (DE) | 2025-11-25 | — | — | US | disclosed |
| US-12358399-B2 | Monitoring health of heat transfer fluids for electric systems | ExxonMobil Technology and Engineering Company (US) | 2025-07-15 | — | — | US | disclosed |
| EP-1385926-B1 | LUBRICATING OIL COMPOSITION COMPRISING AN ADDITIVE COMBINATION OF A CARBOXYLIC ACID AND AN AMINE AS ANT-RUST AGENT | SHELL INT RESEARCH (NL) | 2006-03-01 | — | — | EP | disclosed |
| US-20040214733-A1 | Lubricating oil composition comprising an additive combination of a carboxylic acid and an amine as ant-rust agent | SHELL OIL COMPANY | 2004-10-28 | — | — | US | disclosed |
| EP-1385926-A1 | LUBRICATING OIL COMPOSITION COMPRISING AN ADDITIVE COMBINATION OF A CARBOXYLIC ACID AND AN AMINE AS ANT-RUST AGENT | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 2004-02-04 | — | — | EP | disclosed |
| WO-2002092735-A1 | LUBRICATING OIL COMPOSITION COMPRISING AN ADDITIVE COMBINATION OF A CARBOXYLIC ACID AND AN AMINE AS ANT-RUST AGENT | SHELL INTERNATIONAL RESEARCH MAATSCHAPPIJ B.V. (NL) | 2002-11-21 | — | — | WO | disclosed |
| US-4254823-A | DISPERSION OF THE FIBERS IN AN AQUEOUS SOLUTION CONTAINING A CATIONIC SURFACTANT | BEROL KEMI AB (SE) | 1981-03-10 | — | — | US | disclosed |
| US-4058489-A | NONIONIC, ANIONIC AND AMPHOTERIC SURFACTANTS | BEROL KEMI AB (SW) | 1977-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260081259-A1 | METHOD FOR OPERATING A THERMAL MANAGEMENT ARRANGEMENT | RAF1, PFKP, TP53RK | KDM4C 2641/4885KDM5A 3441/4885PHF8 3834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.